Medicare's Hemp Program Continues Despite Federal Restrictions Taking Effect in Less Than Six MonthsCourt Declines to Address Safety, Legality, or Congressional Intent, Allowing CMS Hemp Program to ...
LONDON, UK / ACCESS Newswire / May 23, 2026 / MYTRT, a UK-based digital healthcare platform, has announced the launch of a service for people seeking information, testing and clinical assessment ...
LONDON--(BUSINESS WIRE)--Ellipses Pharma („Ellipses“), ein weltweit tätiges Unternehmen für die Entwicklung von Krebsmedikamenten mit einer Pipeline innovativer Programme, gab heute bekannt, dass sein ...
VANCOUVER, BC / ACCESS Newswire / May 22, 2026 / GLG Life Tech Corporation (NEX:GLG.H) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality ...
Study conducted with Severance Hospital shows whole-genome sequencing-based HRD phenotyping was associated with longer progression-free survival in patients receiving PARP inhibitor maintenance ...
BFA Law is investigating whether Intuit committed securities fraud relating to its representations about TurboTax’s price positioning among DIY tax filers ahead of and during the 2026 tax season.NEW ...
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE ...
Future facility will serve to broaden access to affordable continuing education and hands-on training for dentists IRVINE, CA / ACCESS Newswire / May 22, 2026 / Glidewell, America's leading dental ...
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with AgiosAvanzanite is ...
Two-year and post-hoc SURPASS-ET analyses highlight the impact of treatment timing, with durable responses and improved progression-free survival supporting consideration of earlier ropeginterferon ...
Law Offices of Howard G. Smith announces an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) investors concerning the Company’s possible violations of federal ...
UK-based study identifies key patient-centered factors influencing treatment preferences in high-risk NMIBCCULVER CITY, Calif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results